Phibro Animal Health Corporation (PAHC)
PAHC Stock Price Chart
Explore Phibro Animal Health Corporation interactive price chart. Choose custom timeframes to analyze PAHC price movements and trends.
PAHC Company Profile
Discover essential business fundamentals and corporate details for Phibro Animal Health Corporation (PAHC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
11 Apr 2014
Employees
1.94k
Website
https://www.pahc.comCEO
Jack Clifford Bendheim
Description
Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro develops, manufactures, and markets products tailored for various food-producing animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its Animal Health offerings encompass a broad range of pharmaceutical and biological products. These include antimicrobials (both chemical and biological agents) designed to prevent and treat bacterial ailments; anticoccidials, primarily used to control and prevent coccidiosis in poultry and cattle; anthelmintics for combating parasitic intestinal worm infestations; and specific anti-bloat treatments for cattle grazing on legume or wheat pastures. Additionally, the company provides specialized nutritional supplements engineered to enhance animal health and performance, alongside vaccines predominantly for the poultry and swine industries to protect against diseases. The Mineral Nutrition segment focuses on the creation and distribution of various trace mineral formulations and concentrates, featuring elements such as zinc, manganese, copper, iron, and other vital compounds. Furthermore, under its Performance Products segment, Phibro supplies an assortment of specialty ingredients that find application in diverse industries, including personal care, industrial chemicals, and chemical catalysts. Phibro's animal health and mineral nutrition products reach customers through a multi-channel distribution network, including its own local sales offices, direct sales to integrated poultry, swine, and cattle operations, and through commercial animal feed producers, wholesalers, and distributors. The company boasts an extensive international presence, conducting business across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region. Initially known as Philipp Brothers Chemicals, Inc., the company adopted the name Phibro Animal Health Corporation in July 2003. It was officially incorporated in 2014 and maintains its corporate headquarters in Teaneck, New Jersey.
PAHC Financial Timeline
Browse a chronological timeline of Phibro Animal Health Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 Aug 2026
EPS estimate is $0.72, while revenue estimate is $381.18m.
Dividend declared on 3 Jun 2026
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 24 Jun 2026.
Earnings released on 6 May 2026
EPS came in at $0.76 surpassing the estimated $0.72 by +5.56%, while revenue for the quarter reached $383.50m , beating expectations by +4.49%.
Dividend declared on 4 Mar 2026
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 25 Mar 2026.
Earnings released on 4 Feb 2026
EPS came in at $0.87 surpassing the estimated $0.69 by +26.09%, while revenue for the quarter reached $373.90m , beating expectations by +5.14%.
Dividend declared on 26 Nov 2025
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 17 Dec 2025.
Earnings released on 5 Nov 2025
EPS came in at $0.73 surpassing the estimated $0.59 by +23.73%, while revenue for the quarter reached $363.90m , beating expectations by +4.87%.
Dividend declared on 3 Sept 2025
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 24 Sept 2025.
Earnings released on 27 Aug 2025
EPS came in at $0.57 surpassing the estimated $0.52 by +9.62%, while revenue for the quarter reached $378.70m , beating expectations by +4.50%.
Dividend declared on 4 Jun 2025
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 25 Jun 2025.
Earnings released on 7 May 2025
EPS came in at $0.63 surpassing the estimated $0.52 by +21.15%, while revenue for the quarter reached $347.80m , missing expectations by -1.25%.
Dividend declared on 5 Mar 2025
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 26 Mar 2025.
Earnings released on 5 Feb 2025
EPS came in at $0.54 surpassing the estimated $0.40 by +35.00%, while revenue for the quarter reached $309.30m , beating expectations by +5.83%.
Dividend declared on 27 Nov 2024
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 18 Dec 2024.
Earnings released on 7 Nov 2024
EPS came in at $0.35 surpassing the estimated $0.25 by +40.00%, while revenue for the quarter reached $260.40m , beating expectations by +5.55%.
Dividend declared on 4 Sept 2024
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 25 Sept 2024.
Earnings released on 28 Aug 2024
EPS came in at $0.41 surpassing the estimated $0.34 by +20.59%, while revenue for the quarter reached $273.20m , beating expectations by +4.88%.
Dividend declared on 5 Jun 2024
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 26 Jun 2024.
Earnings released on 8 May 2024
EPS came in at $0.31 surpassing the estimated $0.29 by +6.90%, while revenue for the quarter reached $263.20m , beating expectations by +3.77%.
Dividend declared on 5 Mar 2024
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 27 Mar 2024.
Earnings released on 8 Feb 2024
EPS came in at $0.33 surpassing the estimated $0.27 by +22.22%, while revenue for the quarter reached $249.90m , beating expectations by +3.72%.
Dividend declared on 28 Nov 2023
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 20 Dec 2023.
Earnings released on 8 Nov 2023
EPS came in at $0.14 falling short of the estimated $0.21 by -33.33%, while revenue for the quarter reached $231.30m , missing expectations by -4.42%.
Dividend declared on 5 Sept 2023
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 27 Sept 2023.
Earnings released on 31 Aug 2023
EPS came in at $0.38 falling short of the estimated $0.40 by -5.00%, while revenue for the quarter reached $255.00m , missing expectations by -0.44%.
Dividend declared on 6 Jun 2023
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 28 Jun 2023.
Earnings released on 4 May 2023
EPS came in at $0.29 falling short of the estimated $0.33 by -12.12%, while revenue for the quarter reached $245.70m , missing expectations by -0.40%.
Dividend declared on 28 Feb 2023
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 22 Mar 2023.
Earnings released on 8 Feb 2023
EPS came in at $0.34 surpassing the estimated $0.30 by +13.33%, while revenue for the quarter reached $244.60m , beating expectations by +1.37%.
Dividend declared on 29 Nov 2022
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 21 Dec 2022.
Earnings released on 9 Nov 2022
EPS came in at $0.21 falling short of the estimated $0.26 by -19.23%, while revenue for the quarter reached $232.50m , beating expectations by +0.18%.
Dividend declared on 6 Sept 2022
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 28 Sept 2022.
Earnings released on 24 Aug 2022
EPS came in at $0.36 falling short of the estimated $0.40 by -10.00%, while revenue for the quarter reached $255.30m , beating expectations by +2.10%.
Dividend declared on 31 May 2022
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 22 Jun 2022.
Earnings released on 4 May 2022
EPS came in at $0.33 falling short of the estimated $0.36 by -8.33%, while revenue for the quarter reached $239.60m , beating expectations by +3.93%.
Dividend declared on 1 Mar 2022
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 23 Mar 2022.
Earnings released on 9 Feb 2022
EPS came in at $0.37 surpassing the estimated $0.33 by +12.12%, while revenue for the quarter reached $232.70m , beating expectations by +8.09%.
Dividend declared on 23 Nov 2021
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 15 Dec 2021.
Earnings released on 2 Nov 2021
EPS came in at $0.25 falling short of the estimated $0.28 by -10.71%, while revenue for the quarter reached $214.67m , beating expectations by +6.15%.
Dividend declared on 31 Aug 2021
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 22 Sept 2021.
Earnings released on 25 Aug 2021
EPS came in at $0.32 matching the estimated $0.32, while revenue for the quarter reached $220.28m , beating expectations by +8.92%.
PAHC Stock Performance
Access detailed PAHC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
